Ramon Coronil retweeted
Ayúdenme a difundirlo.
@MandingaTattoo
Ramon Coronil retweeted
Thrilled to share #PRIMARY2 Trial Results. This is the first randomised trial to show that adding [⁶⁸Ga]Ga-PSMA-11 PET-CT to MRI can safely halve the number of men needing a prostate biopsy.
Hot off the press in @TheLancetOncol 🎉
In 660 men across Australian sites with PI-RADS 2-3 but high clinical risk, PSMA-PET:
- Avoided biopsy in nearly half (49%)
- Was non-inferior for detecting clinically significant cancer (12% vs 16%)
- Halved the overdiagnosis of insignificant cancer (32% to 14%)
Fewer biopsies, less overdiagnosis, whilst not missing clinically significant prostate cancer: a real step forward for the diagnostic pathway.
Enormous congratulations to @ButeauJames @PeterMacCC , who led this as the centrepiece of his PhD and presented it as a plenary at #EAU26 in London. And to my brilliant co-lead @drlouiseemmett - this was a true partnership across our two centres.
Thank you to the UROLOGISTS @DrDanielMoon @declangmurphy (& many others), nuclear medicine physicians, technologists, radiopharmaceutical scientists across every site, and to @AnnetteVDHeyden and the @pros_tic who held it all together.
We are grateful to our funders: @PCF_Science, @nhmrc, St Vincent's Curran Foundation, Peter MacCallum Cancer Foundation, and @ANZUPtrials
Most of all, thank you to the 660 men who took part.
Open Access article: thelancet.com/journals/lanon…
Step into a complete 4-week journey in prostate MRI:
📍 Week 1: PI-RADS & pitfalls
📍 Week 2: Advanced PI-RADS & real AI-assisted cases
📍 Week 3: Active Surveillance with PRECISE v2
📍 Week 4: Recurrence & post-treatment MRI (PI-RR)
📲 More info: quodemy.com/en
📚 ¿Quieres ampliar tus conocimientos en RM de recto y conducto anal?
Súmate a este webinar gratuito junto a la Dra. María Florencia Bambaci
📅 19 de junio - 19 hs (España peninsular) CEST / UTC+2
💻 Modalidad online y gratuita
🔗 Inscríbete en quodemy.com/registro-webinar…
Ramon Coronil retweeted
First images from the GE Omni 128 cm Total Body PET/CT 🚀
The new scanner detected a <5 mm local recurrence of prostate cancer missed by standard PSMA PET/CT - despite 79% shorter acquisition ⏱️
Delayed imaging boosted lesion uptake and informed dose-painted salvage RT 🎯
@JournalofNucMed @PeterMacCC @declangmurphy @_ShankarSiva
jnm.snmjournals.org/content/…
Ramon Coronil retweeted
MRI before prostatectomy isn’t just staging… it’s prognostic.
New meta-analysis in JAMA Oncology shows MRI predicts outcomes independently.
🧵
📌 Study: Pretreatment MRI as prognostic factor after radical prostatectomy
📊 40 studies | 24,941 patients
👨⚕️ Population
Men undergoing radical prostatectomy with pre-treatment MRI
⚔️ Key MRI features → Strong outcome predictors
🔴 Extraprostatic extension (mrT3a)
•BCR: HR 2.16
•Metastasis: HR 3.18
•Cancer-specific mortality: HR 10.9 (!!)
🔴 Seminal vesicle invasion (mrT3b)
•BCR: HR 2.74
•Metastasis: HR 5.58
📊 Quantitative MRI also matters
•PI-RADS 4–5 → HR ~2.1
•Tumor ≥20 mm → HR ~2.35
•Low ADC → HR ~2.4
💡 Key insight
MRI adds independent prognostic value beyond PSA, Gleason, and pathology
👉 Not just imaging
👉 A biologic risk signal before surgery
⚠️ Practice-changing angle
MRI T-staging may be stronger than DRE-based clinical staging
→ Enables better pre-op risk stratification
→ Potential for treatment intensification / de-escalation
🎯 Takeaway
If you’re still using MRI only for staging…
You’re underusing it
MRI = prognosis + decision-making tool
🔖 Save this for clinic discussions
📖 Full paper in comment ⬇️
#OncoTwitter #MedTwitter #ProstateCancer #UroOncology @OncoAlert @myesmo @esmo_open @asco
Ramon Coronil retweeted
El PET PSMA estadifica correctamente.
Alto volumen 40ml or 110ml?
PSMA PET stages accurately.
High volume: 40 mL or 110 mL?
@piet_ost
@APCCC_Lugano
Ramon Coronil retweeted
⭐ UroTerag LATAM APCCC 2026. Adaptando la evidencia al contexto de América Latina
@OncoAlert #APCCC26
@APCCC_Lugano @Silke_Gillessen
@Martin_AngelMD @DBarreiro4 @jpsade2 @DrMHofman @dandanmena @Cdanicas @raymanneh
🚨 Detección precoz en cáncer de próstata en LATAM: tiempo de actuar
🔹 Implementar estrategias de screening en países de ingresos bajos y medios
🔹 Integrar programas en sistemas de salud
🔹 Rol clave de atención primaria + urología
🔹 PSA como herramienta central
🌎 Desigualdad global en acceso sigue siendo crítica
📊 Propuesta:
🔹 Screening desde los 50 años (antes en alto riesgo)
🔹 Seguimiento basado en PSA
🔹 MRI en evaluación urológica
⚠️ Hoy vemos más enfermedad metastásica de la que deberíamos
💡 Tratar enfermedad avanzada cuesta lo mismo que curar precozmente
👉 Time for action
#APCCC26 #ProstateCancer #LATAM #Oncology
Ramon Coronil retweeted
⭐ Are we overtreating patients in the mpMRI / PSMA PET era?
@OncoAlert @APCCC_Lugano #APCCC26 @Silke_Gillessen @AOmlin
Presented by Derya Tilki
🔹 Excellent overview on the strengths and limits of modern imaging
🔹 Key messages:
🔹 1. MRI-derived EPE and seminal vesicle invasion are independently associated with biochemical recurrence and metastatic failure
🔹 2. MRI-based T-staging remains clinically useful — but terminology and reporting need standardization
🔹 3. PSMA PET/CT improves detection of local tumor extension and nodal disease in selected settings
🔹 4. Combining mpMRI + PSMA PET may better define dominant and non-dominant lesions
🔹 5. Imaging–biopsy discordance remains a key challenge in treatment planning
🔹 6. More accurate imaging can improve selection — but may also increase the risk of overtreatment if not interpreted carefully
🔹 Take-home:
Modern imaging should refine decisions, not replace clinical judgment, pathology and multidisciplinary discussion.
@declangmurphy @RenuEapen @DrYukselUrun @fabioturco92 @UrsulaVogl @SScagliarini @Tylersbrt @neerajaiims @amerseburger @Cdanicas @AarmstrongDuke @BertrandTOMBAL @ChrisSweens1 @EAntonarakis @KOSJ12 @VedangMurthy @DrRanaMcKay @LoebStacy @stefanofanti4 @mirrorsmed @profkhermann @dr_coops @piet_ost @_ShankarSiva @DrSpratticus @scocmem @AmandaNizamMD @tompowles1 @brian_rini @Uromigos @EUplatinum @EANM_NucMed @ESTRO_RT @Uroweb
Ramon Coronil retweeted
Randomized comparison of MRI versus transurethral resection for staging new #BladderCancers: Final survival analysis from the #BladderPath trial. Presentation by James Catto, PhD @sheffielduni. #EAU26 written coverage by @zklaassen_md @GACancerCenter > bit.ly/41ef6H3 @Uroweb
Ramon Coronil retweeted
PFS following primary staging with 18F-PSMA-1007-PET/CT vs 18NaF-PET/CT in #ProstateCancer: Results from the PRISMA-PET randomized controlled trial. Presentation by Karen Buch-Olsen. #EAU26 written coverage by @zklaassen_md > bit.ly/4lpvoWS @Uroweb
Ramon Coronil retweeted
🚨 Gamechanger #PRIMARY2 RCT #EAU26, presented and in press @TheLancetOncol. PSMA-PET CT in men with equivocal or -ve MRI but red flags results reduces biopsy by 49% and has non-inferior csPCa detection to template biopsy in all. Proud to be part of this🚨
Clase sobre Ca Próstata: RM y PET-TC - en el primer congreso de la SORPBA 2025. youtu.be/f_VOWkQOD6Q?si=XZYw…
1
103
👏🏻📣 ¡Buena noticia! Debido a las solicitudes recibidas extendemos la fecha de inscripción de nuestro fellow "Resonancia Magnética Prostática".
📲 Ingresa en quodemy.com
Ramon Coronil retweeted
2026 Genitourinary Oncology Spring Refresher - Dry Run
Updates in the management of cancers of the prostate, bladder, kidney, testes, from @NCCN @ASTRO_org @ESTRO_RT @Uroweb
#Radonc residents @ARRO_org, I hope it helps you ace the board exams!
youtu.be/IOQB79eXWH8
Ramon Coronil retweeted
#GU26 Dr. Armstrong presents PCWG4: modernizing prostate cancer trial design
🧭 Updated clinical states model (2016–2025 panel)
🔬 Integrates PSMA PET, ctDNA, CTCs & molecular subtyping
🔹 New imaging-specific rPFS incl. serial PSMA PET guidance
🔹 Standardized delay/prevent endpoints + biomarker timing
🎯 Patient-centric, biology-driven framework for ADT-sensitive & resistant states
✅ PCWG4 sets the roadmap for the PET era
@ASCO @UroToday
Ramon Coronil retweeted
Daro-PET: A phase 2 trial of darolutamide to enhance PSMA expression in patients with localized #ProstateCancer. Presentation by @motajmsc @Icesp_. #GU26 written coverage by @zklaassen_md @GACancerCenter > bit.ly/4sie08Z @ASCO
👏🏻 Felicitamos a Juan de la Morena @juandelamorena_ ganador de la inscripción para nuestro fellowship virtual "Resonancia Magnética Prostática". Todo para la práctica asistencial".
💙 ¡Gracias a todos por participar!
















































